Chinese mpox vaccine gets green light for clinical trials Chinese mpox vaccine gets green light for clinical trials
MONDAY, SEPTEMBER 09, 2024
A domestic mpox vaccine candidate developed by Chinese drugmaker Sinopharm received clearance from the top drug regulator for clinical trials on Monday, representing the nation's first experimental dose to win the trial approval, said the company.